Close
American Drug Delivery & Formulation Summit
Xylem

Sapio Sciences and Ultima Genomics Partner to Advance Multi-Omics Research

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Samsung Biologics Launches CHF 1.46B Acquisition of PolyPeptide to Scale Peptide Capabilities

The global biopharmaceutical contract manufacturing sector is undergoing a...

FDA Proposes New Rule for Drug Manufacturing Registration

The modernization of regulatory frameworks is becoming essential to...

Why Modular GMP Facilities are Scaling Faster Than Ever

The development of a new pharmaceutical manufacturing site has...
- Advertisement -

Partnership delivers global, end-to-end solutions to accelerate genomics research

Sapio Sciences, the science-awareTMย lab informatics platform, today announced a strategic partnership withย Ultima Genomics. The collaboration will make multi-omics workflows more accessible and streamlined for researchers by integrating Sapioโ€™s AI-powered lab informatics solutions with Ultimaโ€™s high-throughput, low-cost sequencing platform. Together, the companies will deliver efficient, traceable, and unified workflows for multi-omics research and clinical genomics.

Ultima Genomics is known for its innovative ultra-high throughput sequencing architecture, designed to drive down sequencing costs and scale beyond conventional technologies. Its multiomics sequencing capabilities allow researchers to study layers of biology beyond DNA sequences alone. Many changes linked to disease occur first in other omic layers, such as in the epigenome with cancer.

Deeper levels of analysis are increasingly important for understanding complex biology, but until now have often required multiple costly assays and fragmented workflows. This integration allows researchers and clinicians to combine Ultimaโ€™s data generation capabilities with Sapioโ€™s analytics, automation, and data management tools for a seamless, end-to-end solution.

Gilad Almogy, CEO and founder of Ultima Genomics, commented, โ€œPartnering with Sapio Sciences aligns with our goals to enable leading sequencing labs and make genomic information more scalable. By integrating our high-throughput, low-cost sequencing platform with Sapioโ€™s AI-powered lab informatics platform, weโ€™re enabling a seamless, scalable solution for multi-omics research and clinical genomics.

Almogy continued, โ€œWeโ€™re excited to empower organizations to accelerate discovery, drive AI-powered insights, and bring high-quality genomics into everyday workflows with unmatched efficiency and traceability.โ€

Key Benefits for Customers

  • Integrated workflows: Unify sequencing and informatics into a single environment, so researchers avoid fragmented assays.
  • Lower cost per sample: Reduce per-sample costs with ultra-high throughput sequencing.
  • Faster discovery cycles: Accelerate discovery cycles with AI-driven analytics and automation.
  • Improved traceability: Ensure compliance through end-to-end data provenance tracking.
  • Future-ready architecture: Support genomics, transcriptomics, proteomics, and other omics fields with a future-ready architecture.

โ€œThis partnership gives Ultimaโ€™s customers a direct path to combining world-class sequencing with equally powerful informatics,โ€ said Andrew Wyatt, chief growth officer at Sapio Sciences. โ€œBy removing workflow complexity, weโ€™re making it easier for labs to manage multi-omics data, gain insights faster, and scale without compromising quality or compliance.โ€

Sapio Sciences Partner Program

The Sapio Sciences Partner Program connects innovators with Sapioโ€™s industry-leading lab informatics platform, fostering integrations that deliver measurable benefits to customers. It includes three partner ecosystems:

  • Technology partners:ย Hardware, cloud, and software vendors that extend the platform through integration, hosting, and solution development.
  • Services partners:ย Advisory and implementation experts who guide customers through lab automation and deployment.
  • Reseller partners:ย Value-Added Resellers (VARs) and consultants who resell Sapio solutions and add value through customization, integration, training, and support.

Discover howย Sapioย Sciences can revolutionize your lab operations at www.sapiosciences.comย and follow us onย LinkedIn.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Samsung Biologics Launches CHF 1.46B Acquisition of PolyPeptide to Scale Peptide Capabilities

The global biopharmaceutical contract manufacturing sector is undergoing a...

FDA Proposes New Rule for Drug Manufacturing Registration

The modernization of regulatory frameworks is becoming essential to...

Why Modular GMP Facilities are Scaling Faster Than Ever

The development of a new pharmaceutical manufacturing site has...

Why Living Drugs Need a New Generation of Fill-Finish

The final stages of the pharmaceutical manufacturing process, where...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป